Colour theme
Theme
Sign in
Insider · CIK 0001886431

Fitzgerald Kevin Joseph

CIK 0001886431 Name as filed on the most recent filing

Filed as Fitzgerald Kevin Joseph (13)

152 transaction lines · from 13 filings · filed 2024-06-26 to 2026-03-06 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

152 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.

Transactions filed by this insider
Direction Date Issuer Code Shares Price Value USD Filing
2026-01-12 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 19 disposed 375.65 7,137.35 Form 4, filing 0001735276-26-000011
2026-01-12 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 19 disposed 370.87 7,046.53 Form 4, filing 0001735276-26-000011
2026-01-12 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 15 disposed 377.82 5,667.30 Form 4, filing 0001735276-26-000011
2026-01-12 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 14 disposed 374.44 5,242.16 Form 4, filing 0001735276-26-000011
2026-01-12 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 2 disposed 372.46 744.92 Form 4, filing 0001735276-26-000011
2025-11-17 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 8,168 disposed 449.00 3,667,432.00 Form 4, filing 0001735276-25-000123
2025-11-17 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 794 disposed 458.41 363,977.54 Form 4, filing 0001735276-25-000123
2025-11-17 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 707 disposed 460.84 325,813.88 Form 4, filing 0001735276-25-000123
2025-11-17 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 622 disposed 459.89 286,051.58 Form 4, filing 0001735276-25-000123
2025-11-17 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 368 disposed 455.24 167,528.32 Form 4, filing 0001735276-25-000123
2025-11-17 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 364 disposed 456.25 166,075.00 Form 4, filing 0001735276-25-000123
2025-11-17 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 323 disposed 461.96 149,213.08 Form 4, filing 0001735276-25-000123
2025-11-17 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 295 disposed 463.08 136,608.60 Form 4, filing 0001735276-25-000123
2025-11-17 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 262 disposed 457.39 119,836.18 Form 4, filing 0001735276-25-000123
2025-11-17 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 129 disposed 451.51 58,244.79 Form 4, filing 0001735276-25-000123
2025-11-17 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 96 disposed 450.09 43,208.64 Form 4, filing 0001735276-25-000123
2025-10-02 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 555 disposed 452.69 251,242.95 Form 4, filing 0001735276-25-000114
2025-10-02 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 449 disposed 450.81 202,413.69 Form 4, filing 0001735276-25-000114
2025-10-02 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 276 disposed 451.86 124,713.36 Form 4, filing 0001735276-25-000114
2025-10-02 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 273 disposed 453.77 123,879.21 Form 4, filing 0001735276-25-000114
2025-10-02 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 207 disposed 449.79 93,106.53 Form 4, filing 0001735276-25-000114
2025-10-02 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 203 disposed 454.84 92,332.52 Form 4, filing 0001735276-25-000114
2025-10-02 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 150 disposed 448.77 67,315.50 Form 4, filing 0001735276-25-000114
2025-10-02 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 122 disposed 457.43 55,806.46 Form 4, filing 0001735276-25-000114
2025-10-02 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 96 disposed 446.53 42,866.88 Form 4, filing 0001735276-25-000114
2025-10-02 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 60 disposed 455.82 27,349.20 Form 4, filing 0001735276-25-000114
2025-10-02 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 47 disposed 447.92 21,052.24 Form 4, filing 0001735276-25-000114
2025-10-02 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 3 disposed 457.64 1,372.92 Form 4, filing 0001735276-25-000114
2025-08-18 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 543 disposed 454.04 246,543.72 Form 4, filing 0001735276-25-000088
2025-08-18 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 329 disposed 452.96 149,023.84 Form 4, filing 0001735276-25-000088
2025-08-18 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 241 disposed 454.84 109,616.44 Form 4, filing 0001735276-25-000088
2025-08-18 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 103 disposed 451.99 46,554.97 Form 4, filing 0001735276-25-000088
2025-08-18 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 90 disposed 449.92 40,492.80 Form 4, filing 0001735276-25-000088
2025-08-18 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 39 disposed 450.92 17,585.88 Form 4, filing 0001735276-25-000088
2025-08-18 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 39 disposed 447.98 17,471.22 Form 4, filing 0001735276-25-000088
2025-08-18 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 12 disposed 455.82 5,469.84 Form 4, filing 0001735276-25-000088
2025-03-04 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 328 disposed 240.95 79,031.60 Form 4, filing 0001735276-25-000034
2025-03-04 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 324 disposed 241.68 78,304.32 Form 4, filing 0001735276-25-000034
2025-03-04 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 121 disposed 239.24 28,948.04 Form 4, filing 0001735276-25-000034
2025-03-04 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 71 disposed 242.93 17,248.03 Form 4, filing 0001735276-25-000034
2025-03-03 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 487 disposed 243.94 118,798.78 Form 4, filing 0001735276-25-000034
2025-03-03 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 465 disposed 242.69 112,850.85 Form 4, filing 0001735276-25-000034
2025-03-03 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 224 disposed 243.36 54,512.64 Form 4, filing 0001735276-25-000034
2025-03-03 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 219 disposed 245.30 53,720.70 Form 4, filing 0001735276-25-000034
2025-03-03 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 204 disposed 242.37 49,443.48 Form 4, filing 0001735276-25-000034
2025-03-03 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 151 disposed 244.41 36,905.91 Form 4, filing 0001735276-25-000034
2025-03-03 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 111 disposed 245.26 27,223.86 Form 4, filing 0001735276-25-000034
2025-03-03 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 45 disposed 246.18 11,078.10 Form 4, filing 0001735276-25-000034
2025-03-03 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 4 disposed 247.35 989.40 Form 4, filing 0001735276-25-000034
2025-03-03 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 1 disposed 248.36 248.36 Form 4, filing 0001735276-25-000034

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale

Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 0
  • Open-market sale 152
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Fitzgerald Kevin Joseph, insider transactions. Retrieved 2026-08-20 from https://ebomi.com/insider/0001886431

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.